Basic Information
Basic information for SNHG14-291-26aa-2
Peptide Name SNHG14-291-26aa-2
Genome Position chr15:25078930-25078995,25081091-25081102[+]
Species Human
Peptide Sequence MAGNPWTHVAWAPLGAGGSLHTVVLV
Peptide Length 26
Unique No (SNHG14-210-26aa-1,SNHG14-248-26aa-2,SNHG14-277-26aa-2,SNHG14-290-26aa,SNHG14-304-26aa-1,SNHG14-305-26aa,SNHG14-318-26aa-2,SNHG14-323-26aa-3,SNHG14-332-26aa-2,SNHG14-340-26aa-1)
Grand Average of Hydropathicity 0.7154
Relative Molecular Mass 3092.51
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000664545;SNHG14-291
Transcript Length 5278
Coding Ability 0.5176
DNA Sequence Corresponding to Peptide ATGGCAGGGAACCCATGGACACATGTGGCATGGGCTCCTTTGGGTGCCGGTGGATCCCTTCATACGGTAGTGTTGGTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :